NOVACCESS GLOBAL
NovAccess Global is building long-term shareholder value through the intelligent acquisition of assets in clinical-stage research and development, balanced with medical assets in the market. The company brings together technological assets, scientific, and executive team to accelerate taking these assets to market.
NOVACCESS GLOBAL
Industry:
Biopharma Biotechnology Medical
Founded:
2020-01-01
Address:
Chesterland, Ohio, United States
Country:
United States
Website Url:
http://www.novaccessglobal.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
175 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Euro PHP Contact Form 7
Similar Organizations
BioFeyn
BioFeyn is enhancing the efficiency and sustainability of marine ingredients for use in aquaculture.
Enterin
Philadelphia-based biotechnology company .
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.novaccessglobal.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.24 K
- Host name: cloudproxy10133.sucuri.net
- IP address: 192.124.249.133
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Novaccess Global"
Home | NovAccess Global
With TLR-AD1, we will provide Novel Access to the Global market. Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in …See details»
Novaccess Global - Crunchbase Company Profile
NovAccess Global is engaged in research to enhance the human body's immune response to cancer, focusing on novel immunotherapy approaches. The company is working on the development and implementation of diagnostics for cancer …See details»
Our Mission - NovAccess Global
NovAccess Global is creating a model that will redefine standards of progress in the effective diagnosis and treatment for cancer patients and patients with other neurological diseases, by synergizing breakthrough advancements in …See details»
NovAccess Global - LinkedIn
Providing Novel Diagnostics & Therapeutics in Cancer and Neurological Diseases | NovAccess Global is a biomedical company accelerating and investing in novel cancer diagnostics and therapeutics.See details»
Team - NovAccess Global
Neil J. Laird is an experienced financial executive who works with emerging companies to provide accounting and finance-related services. Since 2017 he has worked with several technology …See details»
NovAccess Global – A Diversified Biotech and Health Services …
Our patented approach, TLR-AD1, bolsters the body’s own immune system through cellular training; resulting in cancer-fighting cells increasing in number and intelligence. With TLR-AD1, …See details»
NovAccess Global Launches Precision Medicine Division Using AI, …
Jun 1, 2023 · NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to market novel and innovative …See details»
NovAccess Global - Overview, News & Similar companies
Dec 1, 2023 · View NovAccess Global (www.novaccessglobal.com) location in Ohio, United States , revenue, industry and description. Find related and similar companies as well as …See details»
NovAccess Global Announces New License to Advance its …
Apr 30, 2024 · CLEVELAND, OH / ACCESSWIRE / April 30, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing a novel immunotherapy for patients …See details»
NovAccess Global Inc. to Present at the December 7th Virtual …
Dec 1, 2023 · NovAccess Global is a preclinical, IND-ready biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to …See details»
NovAccess Global - VentureRadar
Website: https://novaccessglobal.com/ NovAccess Global, Inc. is building long-term shareholder value through intelligent acquisition of assets in clinical stage research and development, …See details»
NovAccess Global Provides Business Updates and Announces …
Cleveland, OH – March 1, 2024 -- NovAccess Global Inc. (OTCQB: XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an …See details»
NovAccess Global Announces New License to Advance its …
Apr 30, 2024 · NovAccess Global is preparing to submit an Investigational New Drug (IND) application to the FDA for TLR-AD1. In advance of the IND filing, the Company expects to …See details»
NovAccess Global Announces $10.7 Million Financing
Jan 2, 2024 · CLEVELAND, OH / ACCESSWIRE / January 2, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor …See details»
Press Releases - NovAccess Global
Jan 2, 2024 · Revolutionary advances in the understanding of how our bodies can fight cancer, and how to put that information to use in treating existing tumors.See details»
NovAccess Global Provides Business Updates and Announces …
Mar 1, 2024 · CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor …See details»
NovAccess Global | Chagrin Falls OH - Facebook
NovAccess Global, Chagrin Falls, OH. 588 likes. NovAccess Global is a biomedical company accelerating and investing in novel cancer diagnostics and...See details»
NovAccess Global Stock Redemption and Expanded Board of …
Mar 17, 2022 · NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to market novel and innovative …See details»
NovAccess Global Stock Redemption and Expanded Board of …
LOS ANGELES, CA -- March 17, 2022 -- NovAccess Global Inc. (OTC PINK:XSNX) announced today the closing of a series of transactions which results in the reduction of potential common …See details»
NovAccess Global, Inc. Announces Successful Completion of Pre …
NovAccess Global is a biomedical company accelerating novel cancer diagnostics and therapeutics. Our goal is to discover, develop and bring to market novel and innovative …See details»